U.S. pharma giant Pfizer has signed an agreement with China to cooperate on improving the country’s health coverage, according to the company.
“We are aligned very much with the China ‘Healthy 2030’ [initiative] and we are trying to contribute as much as we can,” Pfizer CEO Albert Bourla told CNBC’s Eunice Yoon on Saturday.
He declined to share further details, including dollar amounts.
China in 2016 announced a “Healthy China 2030” plan for improving the country’s public health services, medical industry and food and drug safety. The Covid-19 pandemic also highlighted shortfalls in China’s still-developing public health system.
Pfizer’s memorandum of understanding with the Health China Research Center is set to support public health research and improve the health of rural populations, according to details released by Chinese state media.
“Any individuals and citizens from China would have the same access to our innovative product,” Pfizer China President Jean-Christophe Pointeau said in the report.
He said the company has around 600 staff dedicated to rural areas “to educate the health care professionals on our breakthrough innovation Oncology, Anti-infectives and Inflammation & Immunology.”
The weekend comments did not discuss the Paxlovid drug for treating Covid.
In January, Bourla said Pfizer had signed an agreement with a local partner to manufacture Paxlovid in China, which production could begin in as soon as three or four months.
See all the news
LEADx Change Unveils Season 4 of Leadership Accelerator & Public Square Summit
Forbes to be Acquired by Entrepreneur and Philanthropist Austin Russell
Arrival Hosts Yet Another Successful Metaverse Event: A Recap of the Latest Conference
#საქმიანიდილა - 28 აპრილი - პროლოგი
The company "Tam Management" makes an explanation
#forbesკვირა - ქალაქები,სადაც ცხოვრებაში თანხებს გიხდიან
წერეთლის გამზირის რეაბილიტაცია - სავაჭრო ობიექტების მოლოდინები
როგორ შეიცვალა საცხოვრებელი უძრავი ქონების ფასი 12 წელში?
როდის გაიხსნება რიკოთი?
სახელმწიფო მხარდაჭერის ეფექტიანობა DCFTA-ის ბაზრებზე – ISET-ის კვლევა
#საქმიანისაღამო: ლარის კურსი & გლობალური საფონდო ბირჟების მიმოხილვა / 30.03.2023
"Georgia will be faithful to the European path... I serve this path" - Ambassador of Georgia to France
Cavea plus-ის 6 თვის შედეგები და გამოწვევები
Gold is shining in the new geopolitical world
VR Holding is starting a large-scale and innovative project in Shekvetili
JSC “Rustavi Azot” was sold
We Are Creating An Innovative Co-Working Space In Tbilisi - Sergi Gvarjaladze
State to build Anaklia Port
NG Georgia - თარგმანი ყველა ენაზე
The Rich Often Enjoy Tax Break - Deputy Minister